PFW Advisors LLC Has $1.36 Million Stock Holdings in Stryker Corporation $SYK

PFW Advisors LLC reduced its position in shares of Stryker Corporation (NYSE:SYK) by 8.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,437 shares of the medical technology company’s stock after selling 320 shares during the quarter. PFW Advisors LLC’s holdings in Stryker were worth $1,360,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in SYK. Brighton Jones LLC raised its stake in Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares during the period. Tidal Investments LLC raised its stake in Stryker by 23.3% during the 4th quarter. Tidal Investments LLC now owns 21,551 shares of the medical technology company’s stock worth $7,759,000 after buying an additional 4,073 shares during the period. Vivaldi Capital Management LP acquired a new position in Stryker during the 4th quarter worth approximately $215,000. Vident Advisory LLC raised its stake in Stryker by 11.9% during the 4th quarter. Vident Advisory LLC now owns 18,873 shares of the medical technology company’s stock worth $6,795,000 after buying an additional 2,001 shares during the period. Finally, iSAM Funds UK Ltd acquired a new position in Stryker during the 4th quarter worth approximately $500,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Evercore ISI upped their price target on Stryker from $390.00 to $415.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 8th. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a report on Friday, July 18th. Citigroup reissued a “buy” rating and set a $455.00 price objective (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. BTIG Research reissued a “buy” rating on shares of Stryker in a report on Monday, July 14th. Finally, Truist Financial set a $415.00 price objective on Stryker and gave the stock a “hold” rating in a report on Monday, August 4th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $431.42.

Insider Buying and Selling at Stryker

In other Stryker news, insider Viju Menon sold 500 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider owned 12,511 shares in the company, valued at $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the sale, the director owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. This represents a 5.84% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.20% of the company’s stock.

Stryker Price Performance

Shares of NYSE SYK opened at $376.24 on Wednesday. The stock has a fifty day simple moving average of $388.41 and a two-hundred day simple moving average of $379.42. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The firm has a market cap of $143.84 billion, a price-to-earnings ratio of 49.83, a price-to-earnings-growth ratio of 2.72 and a beta of 0.93. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. During the same period in the prior year, the company earned $2.81 earnings per share. Stryker’s revenue was up 11.1% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s dividend payout ratio is currently 44.50%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.